- Scentre Group maintains its forecast for Funds From Operations (FFO) per security at A$0.2275.
- The company’s FFO per security estimate slightly misses analysts’ expectations of A$0.23.
- Distribution per security is projected to be A$0.1763.
- The analyst ratings for Scentre Group include 5 ‘buy’ recommendations and 5 ‘hold’ suggestions, with no ‘sell’ ratings.
- Comparisons with previous results are based on original disclosures by the company.
“`
A look at Scentre Group Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 4 | |
| Dividend | 4 | |
| Growth | 5 | |
| Resilience | 2 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 3.8 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Based on the Smartkarma Smart Scores, Scentre Group shows a promising long-term outlook. With a strong value score of 4, the company is considered to have attractive fundamentals relative to its current market price. Additionally, a solid dividend score of 4 indicates the company’s ability to generate dividends for its shareholders, enhancing its investment appeal. For growth potential, Scentre Group received a high score of 5, suggesting optimistic prospects for expansion and revenue increase in the future.
However, the company’s resilience score is lower at 2, indicating some vulnerability to economic downturns or other challenges. This aspect may require further scrutiny to ensure sustained performance. Finally, Scentre Group demonstrates strong momentum with a score of 4, reflecting positive market sentiment and potential for continued stock price appreciation. Overall, despite challenges in resilience, Scentre Group‘s favorable scores in value, dividend, growth, and momentum bode well for its future prospects in the retail real estate sector.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
